Literature DB >> 2076269

Diabetic heart muscle disease.

M I Uusitupa1, J N Mustonen, K E Airaksinen.   

Abstract

Diabetic patients may have various abnormalities in left ventricular systolic and diastolic function not attributable to coronary heart disease, hypertension or other known cardiac disease. Although the exact causes of this diabetic heart muscle disease or "diabetic cardiomyopathy" are still incompletely understood, several mechanisms may contribute to it including disturbed myocardial energy metabolism, microvascular changes, structural changes in collagen, increased myocardial fibrosis, and cardiac autonomic neuropathy. Perhaps the most typical feature of diabetic heart muscle disease is an abnormal filling pattern of the left ventricle, suggesting reduced compliance or prolonged relaxation. Left ventricular systolic function is commonly normal at rest in asymptomatic diabetic patients, but it frequently becomes abnormal during exercise. The abnormalities in left ventricular systolic function may be partly reversible along with an improvement of metabolic control of diabetes. It is not known how frequently subclinical abnormalities in left ventricular function in diabetic patients result in clinically manifest heart failure.

Entities:  

Mesh:

Year:  1990        PMID: 2076269     DOI: 10.3109/07853899009147274

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  14 in total

1.  Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant.

Authors:  P Rösen; T Ballhausen; W Bloch; K Addicks
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 2.  Update on Echocardiographic Assessment in Diabetes Mellitus.

Authors:  Ying Wang; Thomas H Marwick
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

Review 3.  Diabetes mellitus and cardiac function.

Authors:  M A Mahgoub; A S Abd-Elfattah
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

4.  Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.

Authors:  Anna Biernacka; Michele Cavalera; Junhong Wang; Ilaria Russo; Arti Shinde; Ping Kong; Carlos Gonzalez-Quesada; Vikrant Rai; Marcin Dobaczewski; Dong-Wook Lee; Xiao-Fan Wang; Nikolaos G Frangogiannis
Journal:  Circ Heart Fail       Date:  2015-05-18       Impact factor: 8.790

5.  Autonomic neuropathy tests correlate with left ventricular mass and cardiac diastolic function in normotensive patients with type 2 diabetes mellitus and without left ventricular hypertrophy.

Authors:  João S Felício; Flávia M Santos; Ana Carolina Cb de Souza; Karem M Felício; Arthur B Ribeiro; Maria T Zanella
Journal:  Exp Clin Cardiol       Date:  2010

Review 6.  Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol?

Authors:  P Rösen; X Du; D Tschöpe
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Proteomic analysis in diabetic cardiomyopathy using bioinformatics approach.

Authors:  Allam Appa Rao; Hanuman Thota; Ramamurthy Adapala; Suresh Babu Changalasetty; Ramachandra Sridhar Gumpeny; Annapurna Akula; Lalitha Saroja Thota; Siva Reddy Challa; M R Narasinga Rao; Undurti N Das
Journal:  Bioinform Biol Insights       Date:  2008-01-21

8.  Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.

Authors:  Carlos Gonzalez-Quesada; Michele Cavalera; Anna Biernacka; Ping Kong; Dong-Wook Lee; Amit Saxena; Olga Frunza; Marcin Dobaczewski; Arti Shinde; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2013-09-30       Impact factor: 17.367

9.  Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts.

Authors:  Keshore R Bidasee; Karuna Nallani; Bruce Henry; U Deniz Dincer; Henry R Besch
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

10.  The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats.

Authors:  R Rösen; A F Rump; P Rösen
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.